fbpx
December 21, 2020

FDA OKs First Adjuvant Drug for Common Lung Cancer FDA OKs First Adjuvant Drug for Common Lung Cancer

The US Food and Drug Administration (FDA) has approved osimertinib (Tagrisso, AstraZeneca) as the first adjuvant treatment for adults with early-stage non-small cell lung cancer (NSCLC) […]
December 21, 2020

FDA Approves Implant as Alternative to ACL Reconstruction FDA Approves Implant as Alternative to ACL Reconstruction

The US Food and Drug Administration (FDA) granted marketing authorization for an anterior cruciate ligament (ACL) implant, intended as an alternative to surgical reconstruction after ACL […]
December 20, 2020

CDC Identifies Next Priority Groups for COVID Vaccine CDC Identifies Next Priority Groups for COVID Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An influential federal advisory panel on Sunday voted to recommend that the […]
December 20, 2020

Second COVID-19 Vaccine Ready for Use, CDC Panel Says Second COVID-19 Vaccine Ready for Use, CDC Panel Says

Moderna’s COVID-19 vaccine — the second now cleared for emergency use in the United States — was endorsed by the Advisory Committee on Immunization Practices (ACIP) […]
December 19, 2020

FDA Grants Emergency Use for Moderna COVID-19 Vaccine FDA Grants Emergency Use for Moderna COVID-19 Vaccine

Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. As expected, the US Food and Drug Administration granted Moderna an emergency use authorization (EUA) […]
December 18, 2020

FDA Expands Belimumab Indication to Adults With Nephritis FDA Expands Belimumab Indication to Adults With Nephritis

The US Food and Drug Administration (FDA) has expanded the indication for belimumab (Benlysta) to adults with active lupus nephritis who are receiving standard therapy. Roughly […]
December 17, 2020

Margetuximab Approved for HER2+ Metastatic Breast Cancer Margetuximab Approved for HER2+ Metastatic Breast Cancer

A new monoclonal antibody that targets HER2+ in breast cancer, margetuximab-cmkb (Margenza), has been approved by the Food and Drug Administration (FDA). The new drug is […]
December 15, 2020

FDA Clears First OTC Rapid At-Home COVID Diagnostic Test FDA Clears First OTC Rapid At-Home COVID Diagnostic Test

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that can be completed at home […]
December 15, 2020

FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab

The US Food and Drug Administration (FDA) has approved a shorter infusion time for ocrelizumab (Ocrevus) for patients with relapsing or primary progressive multiple sclerosis (MS), […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0